. SMS1 and SMS2 protein sequences alignment. * Identical amino acid; :/. Homolog amino acid; bold: SAM domain; italic: transmembrane domain. Figure S2 . Characterization of new SMS1(A) and SMS2 (B) antibodies generated in rabbit after inducing overexpression. Both endogenous (Control) and overexpressed (+SMS1 or +SMS2) proteins were detected using anti-SMS (bottom label SMS1 or SMS2; total protein) or anti-V5 (bottom label V5: overexpressed protein). Immunoreactive bands for SMSs or V5-containing SMSs showed identical electrophoretic mobility, demonstrating specificity of anti-SMS antisera. Other immunoreactive bands could correspond to peptides produced after alternative splicing or oligomeric enzyme forms. SMS antibodies also detected purified SMSs produced in Sf9 cells, which further confirmed the specificity of the antibody (C+).
. Characterization of new SMS1(A) and SMS2 (B) antibodies generated in rabbit after inducing overexpression. Both endogenous (Control) and overexpressed (+SMS1 or +SMS2) proteins were detected using anti-SMS (bottom label SMS1 or SMS2; total protein) or anti-V5 (bottom label V5: overexpressed protein). Immunoreactive bands for SMSs or V5-containing SMSs showed identical electrophoretic mobility, demonstrating specificity of anti-SMS antisera. Other immunoreactive bands could correspond to peptides produced after alternative splicing or oligomeric enzyme forms. SMS antibodies also detected purified SMSs produced in Sf9 cells, which further confirmed the specificity of the antibody (C+). Table S2 . Changes in SMS1-to-SMS2 protein ratio in response to 2OHOA treatment and IC50 for 2OHOA in several human GBM cell lines (data from Figure 3B ). 
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